| Name | Isoquinoline-5-Carbaldehyde |
|---|---|
| Synonyms |
Isoquinoline-5-carbaldehyde
5-Isoquinolinecarboxaldehyde 5-Isoquinolinecarbaldehyde MFCD03412483 |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 331.7±15.0 °C at 760 mmHg |
| Melting Point | 113-116°C |
| Molecular Formula | C10H7NO |
| Molecular Weight | 157.169 |
| Flash Point | 162.4±27.8 °C |
| Exact Mass | 157.052765 |
| PSA | 29.96000 |
| LogP | 1.38 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.687 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H319 |
| Precautionary Statements | P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22;R36 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933499090 |
|
~64%
80278-67-7 |
| Literature: DarPharma, Inc. Patent: US2007/155720 A1, 2007 ; Location in patent: Page/Page column 24 ; US 20070155720 A1 |
|
~63%
80278-67-7 |
| Literature: DARPHARMA, INC. Patent: WO2006/12640 A2, 2006 ; Location in patent: Page/Page column 53 ; WO 2006/012640 A2 |
|
~50%
80278-67-7 |
| Literature: Plobeck; Delorme; Wei; Yang; Zhou; Schwarz; Gawell; Gagnon; Pelcman; Schmidt; Yue; Walpole; Brown; Labare; Payza; St-Ogne; Kamassah; Morin; Projean; Ducharme; Roberts Journal of Medicinal Chemistry, 2000 , vol. 43, # 21 p. 3878 - 3894 |
|
~%
80278-67-7 |
| Literature: US6645975 B1, ; US 6645975 B1 |
|
~%
80278-67-7 |
| Literature: Journal of Medicinal Chemistry, , vol. 45, # 17 p. 3660 - 3668 |
|
~%
80278-67-7 |
| Literature: Zhurnal Obshchei Khimii, , vol. 27, p. 734,739; engl. Ausg. S. 809, 813 |
|
~%
80278-67-7 |
| Literature: Zhurnal Obshchei Khimii, , vol. 27, p. 734,739; engl. Ausg. S. 809, 813 |
|
~%
80278-67-7 |
| Literature: Zhurnal Obshchei Khimii, , vol. 27, p. 734,739; engl. Ausg. S. 809, 813 |
| Precursor 7 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |